Announcements Trials
Browse Landscape

Status

Temporarily not available 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Expanded_access 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Locally Advanced Pancreatic Adenocarcinoma 1KRAS G12V Mutant Advanced Epithelial Cancers 1

Interventions

Insulin Infusion Systems 2Gemcitabine 2Cyclophosphamide 2telisotuzumab vedotin 1pembrolizumab 1fludarabine phosphate 1fludarabine 1Taxes 1FANG vaccine 1Erlotinib Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Temporarily not available × Expanded_access × Gemcitabine × Clear all
NCT07319910 2026-01-06

PANOVA-3CA

NovoCure Ltd.

Temporarily not available
Gastrointestinal

Locally Advanced Pancreatic Adenocarcinoma

NCT05389514 2025-11-20

Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors

Providence Health & Services

Temporarily not available

KRAS G12V Mutant Advanced Epithelial Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡